Fior Markets launched a study titled “Global Cytomegalovirus Treatment Market by Drug Type (Cidofovir, Foscarnet, Valganciclovir, Ganciclovir), Infection Type, Distribution Channel, Region” and Global Forecast 2018-2025.

The global cytomegalovirus treatmentmarket is expected to reach USD xx Million in 2017 to USD xx Million by 2025 at a CAGR of xxduring the forecast periodfrom 2018-2025. Organ transplants is one of key factor for the growth of the market. Prevalence of symptomatic CMV infections is common in HIV so prevalence of HIV also driving the growth.


Drug type is classified intocidofovir, foscarnet, valganciclovir, and ganciclovir. These are few of the most prescribed medication for the treatment of cytomegalovirus. Infection type includes retinitis, pneumonia, gastrointestinal ulcers, encephalitis and others.Distribution channel is divided into hospital pharmacies, retail pharmacies and online pharmacies. Hospital pharmacies are driving the market due to the easy availability of medication and increasing prescription patterns for the treatment of CMV.

Regional Segmentation Analysis:

The market is analysed on the basis of five regions namely North America, Europe, Asia Pacific, South America, and Middle East and Africa. The growth of CMV virus due to increasing awareness regarding the herpes virus and increasing diagnosis rate in developed region such as North America and Europe. According to Centre for Disease Control and Prevention (CDC), around 80,000 cases of CMV infections were diagnosed in U.S. and Europe. Rising prevalence of cytomegalovirus infection in the developing countries is anticipated to grow rapidly owing to the large patient pool, and rise in prevalence of many infectious diseases. Moreover, the government initiatives for the awareness regarding rate disease, growing healthcare expenditure and escalating disposable income are few of the factors responsible the market growth in Asia-Pacific.


Competitive Analysis:

Prominent industry players in the market include Merck & Co. Inc., Cell Medical Ltd., Chimerix, Inc., Affymetrix, Inc., Abbott Laboratories, Inc., Becton, Dickinson and Company, Johnson & Johnson, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd. among others.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211